Front Row Advisors’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.84K | Hold |
18
| – | – | ﹤0.01% | 467 |
|
|
2025
Q4 | $3.74K | Hold |
18
| – | – | ﹤0.01% | 461 |
|
|
2025
Q3 | $2.85K | Sell |
18
-9
| -33% | -$1.39K | ﹤0.01% | 474 |
|
|
2025
Q2 | $4.58K | Sell |
27
-18
| -40% | -$2.67K | ﹤0.01% | 437 |
|
|
2025
Q1 | $6.26K | Hold |
45
| – | – | ﹤0.01% | 400 |
|
|
2024
Q4 | $5.38K | Hold |
45
| – | – | ﹤0.01% | 403 |
|
|
2024
Q3 | $5.03K | Hold |
45
| – | – | ﹤0.01% | 408 |
|
|
2024
Q2 | $4.47K | Hold |
45
| – | – | ﹤0.01% | 749 |
|
|
2024
Q1 | $5.11K | Hold |
45
| – | – | ﹤0.01% | 719 |
|
|
2023
Q4 | $4.61K | Hold |
45
| – | – | ﹤0.01% | 380 |
|
|
2023
Q3 | $3.95K | Hold |
45
| – | – | ﹤0.01% | 717 |
|
|
2023
Q2 | $4K | Hold |
45
| – | – | ﹤0.01% | 703 |
|
|
2023
Q1 | $3K | Buy |
+45
| New | +$3.4K | ﹤0.01% | 756 |
|
|
2022
Q4 | – | Sell |
-45
| Closed | -$3.42K | – | 886 |
|
|
2022
Q3 | $3K | Hold |
45
| – | – | ﹤0.01% | 738 |
|
|
2022
Q2 | $2K | Buy |
45
+1
| +2% | +$57 | ﹤0.01% | 802 |
|
|
2022
Q1 | $3K | Hold |
44
| – | – | ﹤0.01% | 793 |
|
|
2021
Q4 | $2K | Hold |
44
| – | – | ﹤0.01% | 870 |
|
|
2021
Q3 | $2K | Hold |
44
| – | – | ﹤0.01% | 855 |
|
|
2021
Q2 | $2K | Buy |
44
+1
| +2% | +$58 | ﹤0.01% | 858 |
|
|
2021
Q1 | $3K | Buy |
43
+1
| +2% | +$55 | ﹤0.01% | 810 |
|
|
2020
Q4 | $2K | Hold |
42
| – | – | ﹤0.01% | 816 |
|
|
2020
Q3 | $2K | Sell |
42
-133
| -76% | -$6.83K | ﹤0.01% | 813 |
|
|
2020
Q2 | $9K | Sell |
175
-25
| -13% | -$1.29K | 0.01% | 486 |
|
|
2020
Q1 | $10K | Sell |
200
-25
| -11% | -$1.3K | 0.01% | 461 |
|
|
2019
Q4 | $11K | Buy |
225
+15
| +7% | +$775 | 0.01% | 437 |
|
|
2019
Q3 | $10K | Buy |
210
+51
| +32% | +$2.33K | 0.01% | 437 |
|
|
2019
Q2 | $8K | Buy |
159
+39
| +33% | +$1.8K | 0.01% | 474 |
|
|
2019
Q1 | $6K | Sell |
120
-214
| -64% | -$10.7K | ﹤0.01% | 528 |
|
|
2018
Q4 | $15K | Buy |
+334
| New | +$17.4K | 0.01% | 332 |
|
|
2018
Q1 | – | Sell |
-16,393
| Closed | -$1M | – | 949 |
|
|
2017
Q4 | $1M | Buy |
+16,393
| New | +$1.01M | 0.8% | 35 |
|
Other funds holding CAH
VCM
VPM
Front Row Advisors's CAH Position: Q1 2026 in Review
Front Row Advisors held its Cardinal Health (CAH) position steady in Q1 2026 at 18 shares worth $3.84K. The position accounts for ﹤0.01% of the portfolio, ranked #467.
Front Row Advisors first reported a position in CAH in Q4 2017 and has held it in 30 quarters since. The position peaked at $1M in Q4 2017. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Front Row Advisors held 18 shares of Cardinal Health worth $3.84K as of Q1 2026.
- Front Row Advisors left its Cardinal Health share count unchanged in Q1 2026.
- Cardinal Health made up ﹤0.01% of Front Row Advisors's portfolio in Q1 2026, its #467 holding.
- Front Row Advisors first reported a position in Cardinal Health in Q4 2017 and has held it in 30 quarters since.
- Front Row Advisors's Cardinal Health position peaked at $1M in Q4 2017.
- 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Front Row Advisors's 13F filing for Q1 2026, filed 19 May 2026.